126 related articles for article (PubMed ID: 22465173)
1. Gaining precision on the Alzheimer's Disease Assessment Scale-cognitive: a comparison of item response theory-based scores and total scores.
Balsis S; Unger AA; Benge JF; Geraci L; Doody RS
Alzheimers Dement; 2012 Jul; 8(4):288-94. PubMed ID: 22465173
[TBL] [Abstract][Full Text] [Related]
2. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
[TBL] [Abstract][Full Text] [Related]
3. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease.
Ihl R; Ferris S; Robert P; Winblad B; Gauthier S; Tennigkeit F
Int J Geriatr Psychiatry; 2012 Jan; 27(1):15-21. PubMed ID: 21384431
[TBL] [Abstract][Full Text] [Related]
4. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
[TBL] [Abstract][Full Text] [Related]
5. A study of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population.
Hannesdóttir K; Snaedal J
Nord J Psychiatry; 2002; 56(3):201-6. PubMed ID: 12079572
[TBL] [Abstract][Full Text] [Related]
6. Revising the ADAS-cog for a more accurate assessment of cognitive impairment.
Wouters H; van Gool WA; Schmand B; Lindeboom R
Alzheimer Dis Assoc Disord; 2008; 22(3):236-44. PubMed ID: 18580585
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
[TBL] [Abstract][Full Text] [Related]
8. An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
Ben Jemaa S; Attia Romdhane N; Bahri-Mrabet A; Jendli A; Le Gall D; Bellaj T
J Alzheimers Dis; 2017; 60(1):11-21. PubMed ID: 28505978
[TBL] [Abstract][Full Text] [Related]
9. The cardinal features of cognitive and noncognitive dysfunction and the differential efficacy of tacrine in Alzheimer's disease patients.
Talwalker S
J Biopharm Stat; 1996 Nov; 6(4):443-56. PubMed ID: 8969979
[TBL] [Abstract][Full Text] [Related]
10. The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls.
Graham DP; Cully JA; Snow AL; Massman P; Doody R
Alzheimer Dis Assoc Disord; 2004; 18(4):236-40. PubMed ID: 15592137
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
[TBL] [Abstract][Full Text] [Related]
12. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
[TBL] [Abstract][Full Text] [Related]
13. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease.
Cahn-Weiner DA; Grace J; Ott BR; Fernandez HH; Friedman JH
Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):79-87. PubMed ID: 12050470
[TBL] [Abstract][Full Text] [Related]
14. Examining the reliability of ADAS-Cog change scores.
Grochowalski JH; Liu Y; Siedlecki KL
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2016 Sep; 23(5):513-29. PubMed ID: 26708116
[TBL] [Abstract][Full Text] [Related]
15. The characteristics of patients with uncertain/mild cognitive impairment on the Alzheimer disease assessment scale-cognitive subscale.
Pyo G; Elble RJ; Ala T; Markwell SJ
Alzheimer Dis Assoc Disord; 2006; 20(1):16-22. PubMed ID: 16493231
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
Suh GH; Ju YS; Yeon BK; Shah A
Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
[TBL] [Abstract][Full Text] [Related]
17. Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies.
Mecocci P; Bladström A; Stender K
Int J Geriatr Psychiatry; 2009 May; 24(5):532-8. PubMed ID: 19274640
[TBL] [Abstract][Full Text] [Related]
18. Modeling Alzheimer's disease progression using the disease system analysis approach.
Gomeni R; Simeoni M; Zvartau-Hind M; Irizarry MC; Austin D; Gold M
Alzheimers Dement; 2012 Jan; 8(1):39-50. PubMed ID: 21782528
[TBL] [Abstract][Full Text] [Related]
19. How Do Scores on the ADAS-Cog, MMSE, and CDR-SOB Correspond?
Balsis S; Benge JF; Lowe DA; Geraci L; Doody RS
Clin Neuropsychol; 2015; 29(7):1002-9. PubMed ID: 26617181
[TBL] [Abstract][Full Text] [Related]
20. ADAS-cog (Alzheimer's Disease Assessment Scale-cognitive subscale)--validation of the Slovak version.
Kolibas E; Korinkova V; Novotny V; Vajdickova K; Hunakova D
Bratisl Lek Listy; 2000; 101(11):598-602. PubMed ID: 11218956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
